ERICH2 inhibitors are a class of chemical compounds that specifically target and inhibit the ERICH2 protein, a member of the ERICH (Glutamate-Rich) protein family. While the precise biological role of ERICH2 is still being elucidated, proteins in this family are generally involved in cellular signaling, protein-protein interactions, and possibly the regulation of processes such as cell growth or migration. ERICH2 may have functions related to cytoskeletal dynamics, intracellular signaling pathways, or regulatory networks that control cellular responses to external stimuli. By inhibiting ERICH2, researchers can gain insights into its specific role in cellular physiology and how it contributes to the regulation of key biological processes.
The mechanism by which ERICH2 inhibitors function typically involves binding to critical domains within the protein that are responsible for its activity or interactions with other cellular components. These inhibitors might block the ability of ERICH2 to interact with its molecular partners, thereby disrupting its participation in signaling pathways or structural organization. Structurally, ERICH2 inhibitors may mimic the natural binding ligands or substrates of the protein, preventing it from performing its normal functions. Alternatively, they could act allosterically by inducing conformational changes that render the protein inactive. The study of ERICH2 inhibitors is important for understanding how this protein regulates cellular behavior and contributes to processes such as cell communication, structural organization, or signal transduction. By inhibiting ERICH2, researchers can further explore its involvement in cellular networks and gain a more comprehensive understanding of its functional significance in biological systems.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C (PKC), which can phosphorylate proteins and affect signaling pathways that ERICH2 may be part of. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibits phosphoinositide 3-kinases (PI3K), which can affect downstream signaling pathways involving protein synthesis that may interact with ERICH2. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Inhibits p38 MAPK, potentially affecting stress response pathways and the cellular environment of ERICH2. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR, which plays a significant role in protein synthesis and could affect the cellular context of ERICH2. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $163.00 $300.00 $1642.00 | 18 | |
Inhibits calmodulin, which can modulate calcium signaling pathways and affect the regulatory environment of ERICH2. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $178.00 | 25 | |
Inhibits Ca2+/calmodulin-dependent protein kinase II (CaMKII), which might alter signaling pathways involving ERICH2. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $449.00 | 61 | |
Chelates intracellular calcium, potentially disrupting calcium-dependent processes that could influence ERICH2 function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibits MEK, affecting the MAPK/ERK pathway, which may indirectly influence ERICH2's associated signaling pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Inhibits PI3K, potentially affecting the localization and function of proteins that interact with ERICH2. | ||||||
NF449 | 627034-85-9 | sc-478179 sc-478179A sc-478179B | 10 mg 25 mg 100 mg | $199.00 $460.00 $1479.00 | 1 | |
Stabilizes Axin by inhibiting the Wnt signaling pathway, which could disrupt the downstream transcriptional regulation in which TCF23 may play a role. | ||||||